Implantable cardioverter-defibrillator in pregnant women with hypertrophic cardiomyopathy;Implante de cardio-desfibrilador em gestantes com cardiomiopatia hipertrófica

Brazilian Journal of Cardiovascular Surgery

Volumn 25, Issue 3, 2010, Pages 406-409

  de Paula, Leonardo Jorge Cordeiro ^a   Ribeiro, Henrique Barbosa ^a   de Oliveira Júnior, Roberto Márcio ^a   da Silva, Kátia Regina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiomyopathy, hypertrophic; Death, sudden, cardiac; Defibrillators, implantable; Pregnancy

Indexed keywords

EID: 78649967797     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/s0102-76382010000300019     Document Type: Article

References (10)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/ European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42(9):1687-713.
2. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al; Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298(4):405-12.
3. Martinelli Filho M, Zimerman LI, Lorga AM, Vasconcelos JTM, Rassi A Jr, et al. Diretrizes brasileiras de dispositivos cardíacos eletrônicos implantáveis (DCEI). Arq Bras Cardiol. 2007;89(6):e210-37.
4. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation. 1997;96(9):2808-12.
5. Bonini W, Botto GL, Broffoni T, Dondina C. Pregnancy with an ICD and a documented ICD discharge. Europace. 2000;2(1):87-90.
6. Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119(13):1703-10.
7. Abello M, Peinado R, Merino JL, Gnoatto M, Mateos M, Silvestre J, et al. Cardioverter defibrillator implantation in a pregnant woman guided with transesophageal echocardiography. Pacing Clin Electrophysiol. 2003;26(9):1913-4.
8. Merino JL, Peinado R, Silvestre J. Dual-chamber implantable cardioverter defibrillator implantation guided by non-fluoroscopic electro-anatomical navigation. Europace. 2008;10(9):1124-5.
9. Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Circulation. 2007;115(18):2382-9.
10. Lima CEB, Martinelli Filho M, Silva RT, Tamaki WT, Oliveira JC, Martins DC, et al. Portadores de CDI com limiar de desfibrilação elevado: evolução clínica e alternativas terapêuticas. Arq Bras Cardiol. 2008;90(3):177-84.